- Home
- VFS vs BBIO Comparison
VFS vs BBIO Comparison
Compare VFS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- BBIO
- Stock Information
- Founded
- VFS 2017
- BBIO 2015
- Country
- VFS Vietnam
- BBIO United States
- Employees
- VFS N/A
- BBIO N/A
- Industry
- VFS Blank Checks
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VFS Finance
- BBIO Health Care
- Exchange
- VFS Nasdaq
- BBIO Nasdaq
- Market Cap
- VFS 8.2B
- BBIO 6.7B
- IPO Year
- VFS N/A
- BBIO 2019
- Fundamental
- Price
- VFS $3.25
- BBIO $34.25
- Analyst Decision
- VFS Buy
- BBIO Strong Buy
- Analyst Count
- VFS 3
- BBIO 12
- Target Price
- VFS $5.75
- BBIO $57.09
- AVG Volume (30 Days)
- VFS 463.9K
- BBIO 2.9M
- Earning Date
- VFS 06-06-2025
- BBIO 04-29-2025
- Dividend Yield
- VFS N/A
- BBIO N/A
- EPS Growth
- VFS N/A
- BBIO N/A
- EPS
- VFS N/A
- BBIO N/A
- Revenue
- VFS $1,727,262,130.00
- BBIO $127,415,000.00
- Revenue This Year
- VFS N/A
- BBIO $89.10
- Revenue Next Year
- VFS $44.69
- BBIO $57.07
- P/E Ratio
- VFS N/A
- BBIO N/A
- Revenue Growth
- VFS 57.87
- BBIO N/A
- 52 Week Low
- VFS $2.56
- BBIO $21.62
- 52 Week High
- VFS $5.38
- BBIO $39.54
- Technical
- Relative Strength Index (RSI)
- VFS 37.65
- BBIO 50.58
- Support Level
- VFS $3.45
- BBIO $31.77
- Resistance Level
- VFS $3.79
- BBIO $33.93
- Average True Range (ATR)
- VFS 0.13
- BBIO 1.28
- MACD
- VFS -0.04
- BBIO -0.09
- Stochastic Oscillator
- VFS 0.00
- BBIO 57.14
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.